These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27367183)

  • 1. Current concepts of severe asthma.
    Ray A; Raundhal M; Oriss TB; Ray P; Wenzel SE
    J Clin Invest; 2016 Jul; 126(7):2394-403. PubMed ID: 27367183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
    Schoettler N; Strek ME
    Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.
    Wenzel SE
    Am J Respir Crit Care Med; 2021 Apr; 203(7):809-821. PubMed ID: 33326352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma.
    Trivedi A; Pavord ID; Castro M
    Lancet Respir Med; 2016 Jul; 4(7):585-592. PubMed ID: 27230825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of severe asthma in childhood--state of the art and novel perspectives.
    Hedlin G
    Pediatr Allergy Immunol; 2014 Mar; 25(2):111-21. PubMed ID: 24102748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Targets for Biological Therapies of Severe Asthma.
    Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
    Front Immunol; 2020; 11():603312. PubMed ID: 33329598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment of severe asthma.
    Hashimoto S; Bel EH
    Clin Exp Allergy; 2012 May; 42(5):693-705. PubMed ID: 22251278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.
    Hinks TS; Zhou X; Staples KJ; Dimitrov BD; Manta A; Petrossian T; Lum PY; Smith CG; Ward JA; Howarth PH; Walls AF; Gadola SD; Djukanović R
    J Allergy Clin Immunol; 2015 Aug; 136(2):323-33. PubMed ID: 25746968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma from immune pathogenesis to precision medicine.
    Khalaf K; Paoletti G; Puggioni F; Racca F; De Luca F; Giorgis V; Canonica GW; Heffler E
    Semin Immunol; 2019 Dec; 46():101294. PubMed ID: 31387788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
    Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Quality Standard for Identification and Management of Severe Asthma.
    Haughney J; Winders TA; Holmes S; Chanez P; Saul H; Menzies-Gow A;
    Adv Ther; 2020 Sep; 37(9):3645-3659. PubMed ID: 32725419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting interleukins to treat severe asthma.
    Gibeon D; Menzies-Gow AN
    Expert Rev Respir Med; 2012 Aug; 6(4):423-39. PubMed ID: 22971067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndromes of severe asthma.
    Weissler JC
    Am J Med Sci; 2000 Mar; 319(3):166-76. PubMed ID: 10746827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma.
    Hansbro PM; Kim RY; Starkey MR; Donovan C; Dua K; Mayall JR; Liu G; Hansbro NG; Simpson JL; Wood LG; Hirota JA; Knight DA; Foster PS; Horvat JC
    Immunol Rev; 2017 Jul; 278(1):41-62. PubMed ID: 28658552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different endotypes and phenotypes drive the heterogeneity in severe asthma.
    McDowell PJ; Heaney LG
    Allergy; 2020 Feb; 75(2):302-310. PubMed ID: 31267562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for chronic refractory asthma and pipeline developments.
    Polosa R; Casale T
    Drug Discov Today; 2012 Jun; 17(11-12):591-9. PubMed ID: 22306350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of acute asthma.
    Abou-Shala N
    Respir Care Clin N Am; 1995 Dec; 1(2):309-32. PubMed ID: 9390864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypes of refractory/severe asthma.
    Bush A; Fleming L
    Paediatr Respir Rev; 2011 Sep; 12(3):177-81. PubMed ID: 21722846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.